Point-of-care engagement is essential for converting investments in payer negotiations and copay programs into prescriptions.

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, hopes to use the conference to explore how ...

Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global ...

In addition, many adults (67%) also think policymakers should keep access- and coverage-related factors in mind, namely ...

The adoption of biosimilars is increasing, with a predicted global market CAGR of 18%, though uptake varies by market and is influenced by factors like rebate schemes and patent litigation.